DK164484C - Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer, samt fremgangsmaade til fremstilling af laegemiddelformen - Google Patents

Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer, samt fremgangsmaade til fremstilling af laegemiddelformen

Info

Publication number
DK164484C
DK164484C DK136385A DK136385A DK164484C DK 164484 C DK164484 C DK 164484C DK 136385 A DK136385 A DK 136385A DK 136385 A DK136385 A DK 136385A DK 164484 C DK164484 C DK 164484C
Authority
DK
Denmark
Prior art keywords
preparation
surfactive
ionogen
anion
mixtures
Prior art date
Application number
DK136385A
Other languages
Danish (da)
English (en)
Other versions
DK136385A (da
DK164484B (da
DK136385D0 (da
Inventor
Norman Grant Gaylord
Joseph Martin Schor
Original Assignee
Forest Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forest Laboratories filed Critical Forest Laboratories
Publication of DK136385D0 publication Critical patent/DK136385D0/da
Publication of DK136385A publication Critical patent/DK136385A/da
Publication of DK164484B publication Critical patent/DK164484B/da
Application granted granted Critical
Publication of DK164484C publication Critical patent/DK164484C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
DK136385A 1984-03-26 1985-03-26 Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer, samt fremgangsmaade til fremstilling af laegemiddelformen DK164484C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/592,570 US4795327A (en) 1984-03-26 1984-03-26 Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US59257084 1984-03-26

Publications (4)

Publication Number Publication Date
DK136385D0 DK136385D0 (da) 1985-03-26
DK136385A DK136385A (da) 1985-09-27
DK164484B DK164484B (da) 1992-07-06
DK164484C true DK164484C (da) 1992-11-16

Family

ID=24371220

Family Applications (1)

Application Number Title Priority Date Filing Date
DK136385A DK164484C (da) 1984-03-26 1985-03-26 Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer, samt fremgangsmaade til fremstilling af laegemiddelformen

Country Status (9)

Country Link
US (1) US4795327A (fr)
EP (1) EP0157695B1 (fr)
JP (1) JPS60218329A (fr)
CA (1) CA1240925A (fr)
DE (1) DE3583694D1 (fr)
DK (1) DK164484C (fr)
ES (1) ES8607009A1 (fr)
PL (1) PL144347B1 (fr)
YU (1) YU45915B (fr)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585246A1 (fr) * 1985-07-26 1987-01-30 Cortial Procede d'obtention de formes pharmaceutiques solides a liberation prolongee
EP0297866A3 (fr) * 1987-07-01 1989-12-13 The Boots Company PLC Agents thérapeutiques
US4996061A (en) * 1987-10-07 1991-02-26 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol-decongestant combination
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
HU201869B (en) * 1988-12-30 1991-01-28 Egyt Gyogyszervegyeszeti Gyar Process for producing microcapsules of quick dissolving active component
EP0489096B1 (fr) * 1989-08-25 1995-11-15 BIOGLAN IRELAND (R & D) LIMITED Preparations pharmaceutiques et appareil en permettant l'administration
FR2656525A1 (fr) * 1989-12-29 1991-07-05 Delalande Sa Formes d'administration de medicament a liberation controlee et leur procede de fabrication.
SE466130B (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande dietfiberkomposition
SE9003712L (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
SE9003904D0 (sv) * 1990-12-07 1990-12-07 Astra Ab Method for the manufacture of a pharmaceutical dosage form
US5681585A (en) 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5993860A (en) * 1993-06-17 1999-11-30 Venture Lending NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7179486B1 (en) * 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
CA2216215A1 (fr) 1997-04-05 1998-10-05 Isa Odidi Formulations a liberation prolongee, utilisant des polymeres intelligents, avec caracteristiques de mouillabilite opposees, correspondant a une hydrophobie et a une hydrophilie
JP3739410B2 (ja) 1997-07-02 2006-01-25 ユーロ−セルティーク エス．エイ． 安定化された徐放性トラマドール製剤
FR2766708B1 (fr) * 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
FR2766707A1 (fr) * 1997-07-30 1999-02-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethyl-cellulose et/ou de l'ethylcellulose a titre d'agents desintegrants, et procede d'obtention
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
WO2000033818A1 (fr) 1998-12-11 2000-06-15 Nostrum Pharmaceuticals, Inc. Comprime a liberation prolongee contenant un hydrocolloide et un ether de cellulose
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20060034937A1 (en) * 1999-11-23 2006-02-16 Mahesh Patel Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
FR2827517B1 (fr) * 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
AU2003225837B2 (en) * 2002-03-15 2008-11-06 Forest Laboratories Holdings Limited NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
EP2422772A3 (fr) * 2002-09-20 2012-04-18 Alpharma, Inc. Séquestration de sous-unité et compositions et procédés associés
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
JP2006515008A (ja) * 2003-01-28 2006-05-18 コレギウム ファーマシューティカル， インコーポレイテッド 経口投与のためのミルナシプランの多粒子状組成物
WO2004112756A1 (fr) 2003-06-26 2004-12-29 Isa Odidi Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US9561188B2 (en) 2006-04-03 2017-02-07 Intellipharmaceutics Corporation Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
KR101486228B1 (ko) * 2006-06-19 2015-01-26 알파마 파머슈티컬스 엘엘씨 약제학적 조성물
JP2010506833A (ja) * 2006-10-11 2010-03-04 アルファーマ，インコーポレイテッド 医薬組成物
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
EP2155170A2 (fr) * 2007-06-08 2010-02-24 Addrenex Pharmaceuticals, Inc. Formulation à libération prolongée et procédé de traitement d'un dérèglement adrénergique
WO2009088673A2 (fr) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Composition pharmaceutique
CA2709905A1 (fr) * 2007-12-17 2009-06-25 Alfred Liang Composition d'oxycodone a l'epreuve d'un usage abusif
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US8861813B2 (en) * 2008-03-13 2014-10-14 Mallinckrodt Llc Multi-function, foot-activated controller for imaging system
US11304960B2 (en) * 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US9464227B2 (en) * 2014-03-24 2016-10-11 Lamberti Spa Moisturizing agents
WO2016033556A1 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Esters de (17-β)-hydroxy-4-androstène-3-one biodisponibles à l'état solide
WO2016033549A2 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation
EP3609467B1 (fr) * 2017-04-13 2024-02-28 The Procter & Gamble Company Procédé de préparation d'une composition de produit comprenant une particule discrète et une composition de base aqueuse
WO2020014738A1 (fr) * 2018-07-17 2020-01-23 Ferromedica Pty Ltd Formulations de sulfate ferreux et leurs utilisations
US11931441B2 (en) 2018-10-10 2024-03-19 The Procter & Gamble Company Personal care product customized by discrete particles and method of apply thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732335C2 (de) * 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
CA1146866A (fr) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Procede de production d'un compose pharmaceutique a liberation continue sous forme solide
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose

Also Published As

Publication number Publication date
EP0157695A2 (fr) 1985-10-09
YU45915B (sh) 1992-09-07
DE3583694D1 (de) 1991-09-12
YU49585A (en) 1990-12-31
DK136385A (da) 1985-09-27
JPS60218329A (ja) 1985-11-01
CA1240925A (fr) 1988-08-23
PL252614A1 (en) 1985-12-17
EP0157695A3 (en) 1987-05-13
DK164484B (da) 1992-07-06
EP0157695B1 (fr) 1991-08-07
US4795327A (en) 1989-01-03
ES541503A0 (es) 1986-05-16
PL144347B1 (en) 1988-05-31
ES8607009A1 (es) 1986-05-16
DK136385D0 (da) 1985-03-26

Similar Documents

Publication Publication Date Title
DK164484C (da) Fast laegemiddeldoseringsform med reguleret afgivelse og baseret paa blandinger af vandoploeselige ikke-ionogene celluloseethere og anionaktive overfladeaktive stoffer, samt fremgangsmaade til fremstilling af laegemiddelformen
DK546886A (da) Farmaceutisk praeparat til reguleret frigoerelse af aktive stoffer
NO904446D0 (no) Additivkonsentrat for polymere materialer, samt fremstilling av additivkonsentratet.
NO865202L (no) Tyggbart materiale for utlevering av aktive substanser.
DK28480A (da) Fremgangsmaade til fremstilling af tabletter med forsinket frigivelse af det aktive middel i hvilke tabletter frigivelseshastigheden for det aktive middel er fastlagt i forvejen
NO851881L (no) Innretning for avgivelse av flyktige, virksomme materialer.
DK165730C (da) Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling
DK490482A (da) Derivater af cis,endo-2-azabicyclo-(3.3.0)-octan-3-carboxylsyren, fremgangsmaade til deres fremstilling, midler med indhold deraf samt deres anvendelse
NL187022C (nl) Rifamycine derivaten met anti-bacteriele werking, en dergelijke derivaten bevattend farmaceutisch preparaat.
FI851337L (fi) N-aryl-n-(4-piperidinyl)-amider och dessa innehaollande farmaceutiska kompositioner och deras anvaendning.
DK164904C (da) Hydantoinderivater, fremgangsmaade til fremstilling deraf, herbicidt praeparat indeholdende forbindelserne samt anvendelse af forbindelserne ved bekaempelse af ukrudt
DK160969C (da) Fremgangsmaade til fremstilling af toerre, fritflydende pulvere af let oxiderbare stoffer
IT8422142A0 (it) Procedimento di preparazione. cefem composti ad azione farmaceutica e relativo
DK147386D0 (da) Derivater af methylen-bisphosphonsyre, fremgangsmaade til fremstillingaf samme samt farmaceutisk sammensaetning
DE3276164D1 (en) Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
DK537685A (da) Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf
DK6181A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater i tabletform med langvarig afgivelse af det virksomme stof
DK159652C (da) Cholecalciferolderivater, disse derivater til brug som terapeutisk aktive substanser, fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat baseret paa disse cholecalciferolderivater
ES508483A0 (es) "perfeccionamientos en los dosificadores y alimentadores de material en polvo en moldes para la fabricacion de baldosas de cemento y similares".
IT8424159A0 (it) Composizioni farmaceutiche antitumorali e procedimento per laloro preparazione.
DK476685A (da) Alfa-aminoalkyl-alfa-alkylphenylacetonitrilderivater, fremgangsmaade til fremstilling af samme samt farmaceutisk komposition med indhold heraf
DK444589D0 (da) Mikrobiologisk fremgangsmaade til fremstilling af agrarkemisk anvendelige stoffer
DK402083A (da) Sulfamoylbenzophenon-derivater, fremgangsmaade til fremstilling deraf, deres anvendelse samt farmaceutiske praeparater paa basis af disse forbindelser
DK269986D0 (da) Fremgangsmaade til foroegelse af den transdermale afgivelse af laegemidler samt praeparat til transdermal administrering
IT8621526A0 (it) Loro preparazione e medicinali che derivati di metilendiossifenantrene li contengono. e stilbene, procedimento per la

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK